R1 RCM Inc. provides technology-driven solutions that transform the patient experience and financial performance of hospitals, health systems, and medical groups.
R1 Rcm stock last closed at $11.75, down 1.34% from the previous day, and has decreased 23.95% in one year. It has overperformed other stocks in the Health Information Services industry by 0.03 percentage points. R1 Rcm stock is currently +32.47% from its 52-week low of $8.87, and -37.18% from its 52-week high of $18.71.
At the moment, there are 420.28M shares of RCM outstanding. The market cap of RCM is $4.94B. In the last 24 hours, 1.91M RCM shares were traded.
How to Buy R1 Rcm Stock
Wondering how to invest in R1 Rcm stock? Here's how.
Choose where to buy R1 Rcm stock: You need to decide on an online brokerage, but don't worry - we've tested dozens of stock brokerages and apps to help you decide where to buy R1 Rcm stock.
Open your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
Deposit funds into your brokerage account: Select your payment method and add your info.
Evaluate R1 Rcm stock: The R1 Rcm ticker symbol is RCM. Is R1 Rcm stock a good investment? Should you buy shares of RCM? How do RCM's underlying business fundamentals look? Do top analysts think R1 Rcm is a good buy? Why has RCM's stock price moved recently? (Hint: Our stock research tools can help you evaluate if RCM is a good stock to buy).
Execute your RCM buy order: Decide if you will purchase RCM shares at the current market price or use a limit order to buy RCM stock at a specific price.
Get the latest scoop on your RCM investment: Create a watchlist to important notifications about your investment in R1 Rcm stock.
Step 1: Choose where to buy R1 Rcm stock
You need an online brokerage account to access the NASDAQ market and buy RCM shares.
A brokerage account is an investment account that allows you to buy and sell a variety of financial instruments, such as stocks, bonds, mutual funds, and ETFs.
Our preferred brokerage: eToro
We believe that eToro is the best online stock brokerage. eToro gives you:
You can invest in stocks with zero commissions: Invest without commissions.
Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
Access to world financial markets: From Tech to Healthcare, New York to Tokyo — you can fill your portfolio with stocks from the globe's top exchanges.
Social investing: eToro has a community of more than 20 million users globally. Talk to, learn from, and copy the crypto trades of top investors.
Security: eToro is a regulated and licensed brokerage platform.
Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your stock purchase by signing up for an account with eToro now.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Open your brokerage account
Now that you've picked the best brokerage, you'll need to fill out some personal details so you can invest in RCM stock today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Evaluate R1 Rcm stock
Once you have chosen the best place to buy R1 Rcm stock, it's absolutely critical to research their stock before you invest, so you truly understand the risk and opportunity.
R1 Rcm quick stats
RCM Price
$11.75
1w %
-3.77%
1y %
-23.95%
5y %
12.98%
P/E
1,175x
P/B
1.79x
P/S
2.18x
PEG
2.02x
Revenue
$2.25B
Earnings
$3.30M
Fore. Rev. Growth
13.55%
Fore. Earn. Growth
581.13%
Market Cap
$4.94B
Next Earnings
May 2, 2024
Next Dividend
N/A
R1 Rcm Fundamentals
WallStreetZen was designed to help average investors perform more in-depth fundamental analysis quickly.
You can view all of the due diligence checks on RCM's stock page.
What is the fair value of RCM stock?
You can use a variety of different financial metrics, analyses, models, and charts to gauge RCM's intrinsic value.
Using relative valuations metrics:
RCM could be overvalued based on its P/E ratio of 1,175x, relative to Health Information Services industry P/E ratio of 71.4x
RCM could be undervalued based on its P/B ratio of 1.79x, relative to Health Information Services industry P/B ratio of 3.4x
RCM could be overvalued based on its PEG ratio of 2.02x
There are more short-term assets than short-term liabilities on the RCM balance sheet.
Total RCM debt is lower than 5 years ago, relative to shareholder equity.
RCM profit margin has gone up from -3.5% to 0.1% in the past year.
Signs that RCM is not financially healthy:
There are more long-term liabilities than short-term assets on the RCM balance sheet.
RCM's operating cash flow of $340.10M allows it to safely service it's debt of $1.73B.
RCM has a relatively high debt to equity ratio of 0.8.
RCM earnings of $147.90M is not sufficient to cover its interest payments.
Is R1 Rcm stock a Buy, Hold, or Sell, according to analysts?
Out of 12 sell side analysts who research RCM, the consensus analyst rating on RCM is a Buy
It's important to note that analyst forecasts are not recommendations, nor are they investment advice.
Most Recent RCM Analyst Recommendations
Daniel Grosslight, a top 22% analyst from Citigroup upgrades RCM to a strong buy rating and announces their RCM price target of $16.00, on Mar 20, 2024.
Sean Dodge, a top 37% analyst from RBC Capital reiterates RCM with a buy rating and maintains their RCM price target from $19.00 to $19.00, on Mar 7, 2024.
Scott Schoenhaus, a bottom 7% analyst from KeyBanc maintains RCM with a strong buy rating and raises their RCM price target from $13.00 to $17.00, on Feb 29, 2024.
Stephanie Davis, a bottom 3% analyst from Barclays downgrades RCM to a hold rating and maintains their RCM price target from $14.00 to $14.00, on Feb 28, 2024.
Elizabeth Anderson, a bottom 5% analyst from Evercore ISI Group downgrades RCM to a hold rating and raises their RCM price target from $12.00 to $16.00, on Feb 28, 2024.
You can dive deeper into what analysts are forecasting on the R1 Rcm stock forecast page.
Metrics for Advanced RCM Traders
SMA10
12.23
SMA20
12.49
SMA50
12.73
SMA100
11.54
SMA200
13.11
MACD
-0.25
MACD Signal
-0.14
MACD Histogram
-0.1
RSI
30.16
Stochastic %K
7.95
Stochastic %D
6.86
StochRSI %K
0
StochRSI %D
0
Is RCM Making Money?
Last year, RCM earnings were $3.30M. In the past 3 year, RCM's earnings have gone up by -99.16% per year. This was slower than the Health Information Services industry average of -5.48%.
Last year, RCM revenue was $2.25B. In the last five year, RCM's revenue has gone up by 21.02% per year. This was faster than the Health Information Services industry average of 19.8%.
No, R1 Rcm doesn't provide an income stream by paying out dividends.
Get analysis from other investors
One of the primary reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to learn what other community members have to say.
Step 5: Execute your RCM buy order
There are two primary types of orders:
Market order: A market order is an order to buy or sell a stock at the best price on the market. Market orders are mostly sufficient.
Limit order: A limit order lets you buy or sell a stock at a specific price (or better). If you want to be sure you're buying or selling at an exact dollar amount, use a limit order.
Press the Open Trade button and your broker will place the order.
If you need additional help buying stocks on eToro, click the helpful video below:
As of Apr 23, 2024, it costs $11.75 to buy one share of R1 Rcm stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $5, you can buy 0.426 shares of RCM.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.